Bayer completes acquisition of China's Dihon

10 November 2014 - Deborah Wilkes

Archived

Bayer has completed the acquisition of China's Dihon Pharmaceutical for CNY3.6 billion (US$588 million). The German company said it now had "the leading position in the OTC industry in China".

Click tags below for more information on topics:

TCM

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: